gene in people relapsing soon after therapy With all the BCL2 antagonist venetoclax. sixty six Resistance to those agents has actually been linked to these mutations in all over 70% of cases, Though they tend to be subclonal as well as their unique role causing resistance should be established.It is crucial to consider the movement cytometry histog